Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency. - Micalo L; Archie M; Rowe VL; Adewale AP; Pham NV; Li A; Jimenez JC (Journal of vascular surgery. Venous and lymphatic disorders, 2026)